TrialRheumatology (Oxford, England)2017
Secukinumab sustains improvement in signs and symptoms of psoriatic arthritis: 2 year results from the phase 3 FUTURE 2 study.
Iain B McInnes et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
82 papers cite itlatest 60 shown
this paperpooled ittrialcites it